Repurposing neurological drugs for brain cancer therapeutics
Treatment of glioblastoma (GBM) presents significant challenges due to its high degree of heterogeneity and poor prognosis. Recurrence of the
A forum for researchers, students and applicants in the field of cyclodextrin technology
Treatment of glioblastoma (GBM) presents significant challenges due to its high degree of heterogeneity and poor prognosis. Recurrence of the